Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2025-12-25 @ 10:16 PM
Study NCT ID:
NCT00334958
Status:
COMPLETED
Last Update Posted:
2021-06-14
First Post:
2006-06-07
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures
Sponsor:
Eisai Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-02-13
Start Date Type:
ACTUAL
Primary Completion Date:
2009-05-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-05-20
Completion Date Type:
ACTUAL
First Submit Date:
2006-06-07
First Submit QC Date:
None
Study First Post Date:
2006-06-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-04-16
Results First Submit QC Date:
None
Results First Post Date:
2013-02-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-20
Last Update Post Date:
2021-06-14
Last Update Post Date Type:
ACTUAL